Biotech

All Articles

Bicara, Zenas find IPOs to press late-phase properties towards market

.Bicara Therapies and also Zenas Biopharma have actually given new incentive to the IPO market along...

Genentech to shut cancer cells immunology study team

.Genentech is going to shut its cancer cells immunology analysis team, as well as system mind as wel...

Kezar falls sound growth however to verify its truly worth in stage 1 test

.Kezar Life Sciences is falling its own unpromising stage 1 sound lump medicine as the biotech goes ...

Acelyrin drops izokibep, dismisses 3rd of workers

.In spite of izokibep keeping its newfound winning streak in the medical clinic, Acelyrin is actuall...

Rivus' period 2 obesity-related heart failure trial strikes endpoint

.Rivus Pharmaceuticals has plumped up the customers of its fat-busting, muscle-sparing medicine pros...

Ovid stops preclinical work, IV system after soticlestat stop working

.Ovid Rehab actually revealed last month that it was trimming its own head count as the business nav...

Eli Lilly opens up $700M nucleic acid R&ampD facility in Boston ma Port

.Eli Lilly has opened a $700 thousand R&ampD facility in the Boston ma Seaport, increasing its RNA a...

Boundless Biography helps make 'small' layoffs five months after $100M IPO

.Simply 5 months after safeguarding a $100 million IPO, Vast Bio is actually already laying off some...

Halda's $126M will certainly advance 'secure as well as get rid of' lump drugs

.The first phases of oncology R&ampD may not be except appealing brand new techniques, as well as Ha...

Lykos 'disappointments' certainly not divulging study offenses along with author

.Psychopharmacology has pulled three short articles about midstage scientific trial records determin...